U.S. NALOXONE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Table of Contents

1. Research Objectives and Assumptions

   • Research Objectives
   • Assumptions
   • Abbreviations

2. Market Purview

   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snapshot, By Drug Type
     • Market Snapshot, By Route of Administration
     • Market Snapshot, By Distribution Channel
     • Market Snapshot, By Region
   • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

   • Market Dynamics
     • Drivers
     • Restraints
     • Opportunities
   • Impact Analysis
   • Market Trends
   • Key Developments
   • Regulatory Scenario
   • Acquisitions and Partnerships Scenario
   • Funding and Investments
   • PEST Analysis
   • Porter’s Analysis

4. U.S. Naloxone Market, By Drug Type, 2021 – 2033, (USD Mn)

   • Overview
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 – 2033
     • Segment Trends
   • Branded
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
   • Generic
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)

5. U.S. Naloxone Market, By Route of Administration, 2021 – 2033, (USD Mn)

   • Overview
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 – 2033
     • Segment Trends
   • Intranasal Administration
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
   • Intramuscular Administration
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
   • Intravenous Administration
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
   • Others
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)

6. U.S. Naloxone Market, By Distribution Channel, 2021 – 2033, (USD Mn)

   • Overview
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 – 2033
     • Segment Trends
   • Hospitals Pharmacies
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
   • Retail Pharmacies
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
   • Online Pharmacies
     • Overview
     • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)

7. Competitive Landscape

   • Company Profiles
     • Adapt Pharma Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Mylan N.V.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Hospira Inc. (Pfizer Inc.)
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Kaleo Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Amphastar Pharmaceuticals Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Emergent BioSolutions Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Indivior PLC
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Akorn, Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Hikma Pharmaceuticals PLC
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Viatris Inc.
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Sandoz (a Novartis division)
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Teva Pharmaceuticals
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Amneal Pharmaceuticals
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Somerset Pharma, LLC
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Orexo AB
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • UCB Pharma
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • West Ward Pharmaceuticals
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies
     • Purdue Pharma
       • Company Highlights
       • Product Portfolio
       • Key Highlights
       • Financial Performance
       • Market Strategies

8. Analyst Recommendations

   • Wheel of Fortune
   • Analyst View
   • Coherent Opportunity Map

9. Research Methodology

   • References
   • Research Methodology
   • About us and Sales Contact